Review of biological mechanisms and pharmacological treatments of comorbid PTSD and substance use disorder
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Posttraumatic stress disorder (PTSD) and alcohol/substance use disorder (A/SUD) are frequently comorbid. Comorbidity is associated with poorer psychological, functional, and treatment outcomes than either disorder alone. This review outlines biological mechanisms that are potentially involved in the development and maintenance of comorbid PTSD and A/SUD including neurotransmitter and hypothalamic-pituitary-adrenal dysregulation, structural differences in the brain, and shared genetic risk factors. The literature regarding pharmacological treatments that have been investigated for comorbid PTSD and A/SUD is also reviewed. Empirical data for each proposed mechanism and pharmacological approach is reviewed with the goal of making recommendations for future research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Meta-Analytic Review of Psychosocial Interventions for Substance Use Disorders
Dutra, L., Stathopoulou, G., Basden, S. L., Leyro, T. M., Powers, M. B., & Otto, M. W. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06111851 · Cited by 1,287
Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor
Ressler, K. J., Mercer, K. B., Bradley, B., Jovanovic, T., Mahan, A., Kerley, K., Norrholm, S. D., Kilaru, V., Smith, A. K., Myers, A. J., et al. (2011) · Nature · doi:10.1038/nature09856 · Cited by 800
Oral topiramate for treatment of alcohol dependence: A randomised controlled trial
Johnson, B. A., Ait-Daoud, N., Bowden, C. L., DiClemente, C. C., Roache, J. D., Lawson, K., Javors, M. A., & Ma, J. Z. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13370-3 · Cited by 743
Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.5.624 · Cited by 721 · cited 1×
“Elevated levels of CRH have been found in humans going through withdrawal (Adinoff et al., 1996) and in adults with PTSD (Baker et al., 1999; Bremner et al., 1997).”
BackgroundNonresponse and Dropout Rates in Outcome Studies on PTSD: Review and Methodological Considerations
Schottenbauer, M. A., Glass, C. R., Arnkoff, D. B., Tendick, V., & Gray, S. H. (2008) · Psychiatry: Interpersonal and Biological Processes · doi:10.1521/psyc.2008.71.2.134 · Cited by 634 · cited 1×
“In addition, studies of PTSD and/or A/SUD have high dropout rates from research (Dutra et al., 2008; Schottenbauer et al., 2008) However, prospective studies using multiple and comprehensive methods of assessment are needed to further our understanding of the complex interplay of these disorders.”
BackgroundCorticotropin-releasing factor, norepinephrine, and stress
Koob, G. F. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00164-x · Cited by 629 · cited 1×
“Koob (1999) suggested the interaction between CRH and the noradrenergic system may mediate hyperarousal symptoms in PTSD. Individuals with PTSD may be drawn to substance use in an attempt to attenuate this feedforward cycle to reduce the activity of the locus ceruleus (Kosten and Krystal, 1988).”
BackgroundThe Dopamine D2 Receptor Locus as a Modifying Gene in Neuropsychiatric Disorders
Comings, D. E. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03470130073032 · Cited by 587 · cited 3×
“Comings et al. (1991) examined the relationship between a variant in the dopamine receptor gene (DRD2) and comorbid PTSD and A/SUD, and reported that the presence of TaqI A1 allele was not associated with PTSD and AUD.”
BackgroundInfluentialPiazza, P. V., Deminiere, J. M., le Moal, M., & Simon, H. (1990) · Brain Research · doi:10.1016/0006-8993(90)90431-a · Cited by 565
Topiramate for Treating Alcohol Dependence<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
Johnson, B. A. (2007) · JAMA · doi:10.1001/jama.298.14.1641 · Cited by 542
Baker, D. G., West, S. A., Nicholson, W. E., Ekhator, N. N., Kasckow, J. W., Hill, K. K., Bruce, A. B., Orth, D. N., & Geracioti, T. D. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.4.585 · Cited by 531
Cited by
Torchalla, I., Nosen, L., Rostam, H., & Allen, P. (2012) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2011.09.001 · Cited by 174
Wilkinson, S. T., Stefanovics, E., & Rosenheck, R. A. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m09475 · Cited by 145
Post-traumatic psychiatric disorders: PTSD is not the only diagnosis
Auxéméry, Y. (2018) · La Presse Médicale · doi:10.1016/j.lpm.2017.12.006 · Cited by 122
Hien, D. A., Morgan-López, A. A., Saavedra, L. M., Ruglass, L. M., Ye, A., López-Castro, T., Fitzpatrick, S., Killeen, T. K., Norman, S. B., Ebrahimi, C. T., et al. (2023) · American Journal of Psychiatry · doi:10.1176/appi.ajp.22010071 · Cited by 99
Epigenetic alterations of the BDNF gene in combat‐related post‐traumatic stress disorder
Kim, T. Y., Kim, S. J., Chung, H. G., Choi, J. H., Kim, S. H., & Kang, J. I. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12675 · Cited by 76
“According to the common factors hypothesis, the association between PTSD and alcohol use disorders would be attributable to shared biological vulnerability factors (53).”
BackgroundSaavedra, L. M., Morgan-López, A. A., Hien, D. A., López-Castro, T., Ruglass, L. M., Back, S. E., Fitzpatrick, S., Norman, S. B., Killeen, T. K., Ebrahimi, C. T., et al. (2021) · Contemporary Clinical Trials · doi:10.1016/j.cct.2021.106479 · Cited by 31
Self-citationGong, A. T., Kamboj, S. K., & Curran, H. V. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00092 · Cited by 27
Vanderkam, P., Solinas, M., Ingrand, I., Doux, N., Ebrahimighavam, S., Jaafari, N., & Lafay‐Chebassier, C. (2021) · Addiction · doi:10.1111/add.15265 · Cited by 25
Fortier, C. B., Whitworth, J. W., Fonda, J. R., Currao, A., Beck, B. M., Levin, L., Esterman, M., Milberg, W. P., & McGlinchey, R. E. (2021) · Alcohol and Alcoholism · doi:10.1093/alcalc/agaa075 · Cited by 14
Metadata
- Authors
- Norman, S. B., Myers, U. S., Wilkins, K. C., Goldsmith, A. A., Hristova, V., Huang, Z., McCullough, K. C., & Robinson, S. K.
- Venue
- Neuropharmacology
- Publisher
- Elsevier BV
- Published
- 2012-02
- Volume
- 62
- Issue
- 2
- Pages
- 542-551
- ISSN
- 0028-3908 (ISSN-L)
- OpenAlex
- W2136230152
- Cited by
- 96
- References
- 22
- FWCI
- 5.29
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.